Damachi, U., Dosreis, S., Onukwugha, E., Mysore, M. M., Gopalakrishnan, M., & Castillo, W. C. (2025). RWD169 Real-World Utilization and Predictors of Neurohormonal Inhibitors Use in Young and Middle-Aged Breast Cancer Patients, Initiating Anthracycline-Based Treatments. Value in health, 28(6), S394. https://doi.org/10.1016/j.jval.2025.04.1752
Chicago-Zitierstil (17. Ausg.)Damachi, Udim, Susan Dosreis, Eberechukwu Onukwugha, Manu M. Mysore, Mathangi Gopalakrishnan, und Wendy Camelo Castillo. "RWD169 Real-World Utilization and Predictors of Neurohormonal Inhibitors Use in Young and Middle-Aged Breast Cancer Patients, Initiating Anthracycline-Based Treatments." Value in Health 28, no. 6 (2025): S394. https://doi.org/10.1016/j.jval.2025.04.1752.
MLA-Zitierstil (9. Ausg.)Damachi, Udim, et al. "RWD169 Real-World Utilization and Predictors of Neurohormonal Inhibitors Use in Young and Middle-Aged Breast Cancer Patients, Initiating Anthracycline-Based Treatments." Value in Health, vol. 28, no. 6, 2025, p. S394, https://doi.org/10.1016/j.jval.2025.04.1752.